| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/02/2001 | WO2001054486A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 08/02/2001 | WO2001054474A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001054473A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001054472A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001019997A3 BASB128 polypeptide and polynucleotide from moxarella catarrhalis |
| 08/02/2001 | WO2001019854A3 Neurotransmitter transporter |
| 08/02/2001 | WO2001018048A3 Smooth muscle cell promoter and uses thereof |
| 08/02/2001 | WO2001016303A3 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 08/02/2001 | WO2001016149A3 2-azapurine compounds and their use |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001011053A3 Soluble, active recombinant human mao-b |
| 08/02/2001 | WO2001009327A3 Method of preventing the injury or death of retinal cells and treating ocular diseases |
| 08/02/2001 | WO2001007624A3 Dna sequences which are suited for specifically detecting pseudomonas putida kt2440 |
| 08/02/2001 | WO2001007065A3 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 08/02/2001 | WO2001005950A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | WO2001005826A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 08/02/2001 | WO2001005808A3 In vitro selection and optional identification of polypeptides using solid support carriers |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004155A3 Feline interleukin-12 as an immune stimulant |
| 08/02/2001 | WO2001004146A3 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 08/02/2001 | WO2001004144A3 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 08/02/2001 | WO2001002592A9 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 08/02/2001 | WO2001000234A3 Methods and compositions for engineering of attenuated vaccines |
| 08/02/2001 | WO2000071711B1 Differentially expressed genes in prostate cancer |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000066777A3 Assay based on the analysis of dna melting curves |
| 08/02/2001 | WO2000065070A9 Cell culture process for glycoproteins |
| 08/02/2001 | WO2000065067A3 Prostate-specific polynucleotides, polypeptides and their methods of use |
| 08/02/2001 | WO2000061808A3 Methods for detecting nucleic acids indicative of cancer |
| 08/02/2001 | WO2000061771A9 Transgenic plants containing altered levels of sterol compounds and tocopherols |
| 08/02/2001 | WO2000056932A3 Germline-competent avian cells |
| 08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
| 08/02/2001 | WO2000050593A8 Beta-tubulin autoantibody in meniere's disease and other inner ear diseases and a diagnostic method |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000050451A3 Protein (tp) that is involved in the development of the nervous system |
| 08/02/2001 | WO2000047715A9 Dwf4 polynucleotides, polypeptides and uses thereof |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO2000043514A9 Human acid sensing ion channel and uses thereof |
| 08/02/2001 | WO2000040697A9 Methods and compositions for isolation of nucleic acid molecules |
| 08/02/2001 | WO2000036151A9 A heterogeneous assay for pyrophosphate detection |
| 08/02/2001 | WO2000036106A9 Non-invasive evaluation of physiological response in a mammal |
| 08/02/2001 | WO2000026666A9 Multiple marker characterization of single cells |
| 08/02/2001 | WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | WO1999064587A8 Polypeptides with beta-secretase type activity |
| 08/02/2001 | WO1999049025A3 Human vault rna |
| 08/02/2001 | US20010011381 Genetic engineering |
| 08/02/2001 | US20010011380 Administering drugs comprising kunitzt type inhibitors as antiedemic, anticoagulant, antiischemic or antiinflammatory agents |
| 08/02/2001 | US20010011379 Mutant which interfers with virus reproduction during infection |
| 08/02/2001 | US20010011378 Isotype of starch synthase |
| 08/02/2001 | US20010011377 Adjustment of seed protein profile |
| 08/02/2001 | US20010011139 Polynucleotides labeled with dibenzorhodamine dyes |
| 08/02/2001 | US20010011130 Materials and methods for detection of oxalate |
| 08/02/2001 | US20010011129 Immobilized analytical element |
| 08/02/2001 | US20010011128 Insertion of promoters; gene therapy |
| 08/02/2001 | US20010011127 Modulating activity of endogenous protein |
| 08/02/2001 | US20010011126 Isolated protein; genetic engineering |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011078 DNA fragmentation factor involved in apoptosis |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010011073 Uses of transgenic animals containing a type X collagen mutant |
| 08/02/2001 | US20010010935 Useful in treating stem cells in a patient undergoing chemotherapy |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010933 Configuration; vectors; recombinants |
| 08/02/2001 | US20010010932 Nematicidal proteins |
| 08/02/2001 | US20010010931 Allosteric regulation; gene expression; nucleic acid sequence; chimera |
| 08/02/2001 | US20010010929 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 08/02/2001 | US20010010928 Protozoan expression system |
| 08/02/2001 | US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010921 Cell-free and cell-based assays for screening drugs to treat eating disorders; dietetics; obesity, cachexia |
| 08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 08/02/2001 | US20010010917 Method and device for preparing samples for detecting a nucleotide sequence |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010912 nrdF |
| 08/02/2001 | US20010010909 Isolated nucleic acid encodes a histone deactylase protein |
| 08/02/2001 | US20010010908 Reagents and methods useful for detecting diseases of the prostate |
| 08/02/2001 | US20010010907 Crosslinking transcription factor to nucleic acids |
| 08/02/2001 | US20010010905 Amplification; measurement |
| 08/02/2001 | US20010010904 Genetic engineering; overlapping Dna sequences |
| 08/02/2001 | US20010010900 Transducing phages |
| 08/02/2001 | US20010010899 Genetic engineering |
| 08/02/2001 | US20010010815 Adeno-associated vector compositions for expression of factor VIII |
| 08/02/2001 | US20010010814 Adenoviral vector encoding pro-apoptotic bax gene and uses thereof |
| 08/02/2001 | EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | EP1144440A3 Neurotransmitter transporter |
| 08/02/2001 | DE19955352A1 Streptococcus-Proteine und ihre Verwendung Streptococcus proteins and their use |
| 08/02/2001 | DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells |
| 08/02/2001 | DE10003373A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003372A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003371A1 Rekombinante Attenuation von PRRSV Attenuation of recombinant PRRSV |
| 08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
| 08/02/2001 | DE10002803A1 System zur internen qualitativen und quantitativen Validierung von Markerindices System of internal qualitative and quantitative validation of marker indices |
| 08/02/2001 | DE10001377A1 bHLH-Transkriptionsfaktor ASCL3 und diesen enthaltendes Arzneimittel bHLH transcription factor AsCl3 and this medicinal product containing |
| 08/02/2001 | DE10001372A1 Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen Anti-CD3 single-chain antibody with human Cmu3- and Cmu4- domains |